Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
72 hedge funds and large institutions have $135M invested in Repros Therapeutics Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 15 closing their positions.
131% more call options, than puts
Call options by funds: $9.51M | Put options by funds: $4.11M
88% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 80 → 72 (-8)
16% less capital invested
Capital invested by funds: $160M → $135M (-$24.9M)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.57M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$2.09M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.02M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$600K |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$581K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
-$4.65M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.5M |
| 3 |
ST
Spot Trading
Chicago,
Illinois
|
-$1.03M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$997K |
| 5 |
Goldman Sachs
New York
|
-$952K |
RPRX Hedge Fund Activity: Q1 2015 in Review
72 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q1 2015, worth a combined $135M — down 16% from $160M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of RPRX and 7 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 30 added.
The largest buyer was Millennium Management, adding an estimated $2.57M. The largest seller was Senzar Asset Management, cutting an estimated $4.65M.
- 72 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q1 2015, down from 80 in Q4 2014.
- Funds reported $135M of Repros Therapeutics Inc. stock for Q1 2015, down 16% quarter-over-quarter.
- 7 funds opened new Repros Therapeutics Inc. positions in Q1 2015 and 15 closed out, a net change of -8 holders.
- The largest Repros Therapeutics Inc. buyer in Q1 2015 was Millennium Management, an estimated $2.57M added.
- The largest Repros Therapeutics Inc. seller in Q1 2015 was Senzar Asset Management, an estimated $4.65M sold.
Based on aggregated 13F filings for Q1 2015.